Author

Alessandro Armuzzi 1

1 CIC, Università Cattolica ~ Roma ~ Italy,Roma,Italy

ECCO Guidelines on Therapeutics in Crohn's Disease: medical treatment

Joana Torres, Stefanos Bonovas, Glen A Doherty, Torsten Kucharzik, Javier Gisbert, Tim Raine, Michel Adamina, Alessandro Armuzzi, Oliver Bachmann, Palle Bager, Livia Biancone, Bernd Bokemeyer, Peter Bossuyt, Johan Burisch, Paul Collins, Alaa El-Hussuna, Pierre Ellul, Cornelia Frei-Lanter, Federica Furfaro, Christian Gingert, Paolo Gionchetti, Fernando Gomollón, Marien González-Lorenzo, Hannah Gordon, Tibor Hlavaty, Pascal Juillerat, Konstantinos H. Katsanos, Uri Kopylov, Eduards Krustins, Theodore Lytras, Christian Maaser, Fernando Jose Magro Dias, John K. Marshall, Pär Myrelid, Gianluca Pellino, Isadora Rosa, João Sabino, Edoardo Vincenzo Savarino, Antonino Spinelli, Laurents Stassen, Mathieu Uzzan, Stephan Vavricka, Bram Verstockt, Janindra Warusavitarne, Oded Zmora, Gionata Fiorino

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Jean François Rahier, Fernando Jose Magro Dias, C Abreu, Alessandro Armuzzi, Shomron Ben-Horin, Yehuda Chowers, Mario Cottone, Lissy de Ridder, Glen A Doherty, Robert Ehehalt, Maria Esteve Comas, Konstantinos H. Katsanos, Charlie Lees, E MacMahon, Tom Moreels, Walter Reinisch, Herbert Tilg, L Tremblay, Gigi Veereman, N V

CANCER AND INFLAMMATORY BOWEL DISEASE PHENOTYPE: A PROSPECTIVE MULTICENTER NESTED CASE-CONTROL IG-IBD STUDY

Livia Biancone, Alessandro Armuzzi, Maria Lia Scribano, Renata D'Inca', Claudio Papi, Luisa Spina, Erika Angelucci, Carmelina Petruzziello, Luisa Guidi, Anna Kohn, Filippo Mocciaro, Patrizia Alvisi, Alessandra Ruffa, Rita Monterubbianesi, Walter Fries, Gabriele Riegler, Marco Daperno, Fabiana Castiglione, Giovanna Condino

ASSESSMENT OF LOSS OF RESPONSE TO INFLIXIMAB THERAPY IN INFLAMMATORY BOWEL DISEASES USING ANTIBODIES TO INFLIXIMAB AND TROUGH LEVELS.

Luisa Guidi, Manuela Marzo, Carla Felice, Daniela Pugliese, Gianluca Andrisani, Giammarco Mocci, Olga Maria Nardone, Gian Lodovico Rapaccini, Alfredo Papa, Alessandro Armuzzi, Gian Lodovico Rapaccini

CHARACTERIZATION OF INCIDENT CASES OF CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN A MULTICENTER CASE-CONTROL STUDY

Livia Biancone, Carmelina Petruzziello, Alessandro Armuzzi, Anna Kohn, Renata D'Incà, Claudio Papi, Luisa Spina, Luisa Guidi, Maria Lia Scribano, Emma Calabrese, Giovanna Condino, Sara Onali, Filippo Mocciaro, Rita Monterubbianesi, Patrizia Alvisi, Walter Fries, Gabriele Riegler, Giovanna Margagnoni, Roberto Di Mitri, Gi

Amgen - The emerging treatment landscape of IBD: role of innovator biologics and biosimilars (Amgen Europe GmbH)

Alessandro Armuzzi, Jean-Frederic Colombel, Walter Reinisch

High versus standard adalimumab induction dosing regimens in patients with moderately to severely active ulcerative colitis: results from the SERENE-UC induction study

Julian Panés, Jean-Frederic Colombel, Geert R. D'Haens, Stefan Schreiber, Remo Panaccione, Laurent Peyrin-Biroulet, Edward Loftus, Jr, Silvio Danese, Edouard Louis, Alessandro Armuzzi, Marc Ferrante, Harald Vogelsang, Jessica Lefebvre, Thao Doan, Nisha V. Kwatra, Nael M. Mostafa, Wangang Xie, Bidan Huang, Joel Petersson;;

LONG-TERM OUTCOMES OF ULCERATIVE COLITIS PATIENTS ON MONOTHERAPY MAINTENANCE TREATMENT WITH THIOPURINES: PRELIMINARY DATA

Daniela Pugliese, Pietro Manuel Ferraro, Annalisa Aratari, Giovanna Margagnoni, Rita Monterubbianesi, Carla Felice, Alfredo Papa, Luisa Guidi, Anna Kohn, Claudio Papi, Alessandro Armuzzi

Janssen - Crohn’s disease: supporting patients in their pursuit of disease control (Janssen)

Laurent Peyrin-Biroulet, Alessandro Armuzzi, Severine Vermeire

Management of stricturing Crohn's disease: The surgeons' view

Alessandro Armuzzi, Antonino Spinelli

Item 1 - 10 / 59
1
2 3 4 5 6